KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Enterprise Value Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.85%
Dec 31, 2025 9.22%
Sep 30, 2025 6.63%
Jun 30, 2025 -1.31%
Mar 31, 2025 34.05%
Dec 31, 2024 32.69%
Sep 30, 2024 7.41%
Jun 30, 2024 -19.35%
Mar 31, 2024 -28.09%
Dec 31, 2023 -9.65%
Sep 30, 2023 -8.57%
Jun 30, 2023 -18.47%
Mar 31, 2023 6.71%
Dec 31, 2022 1.24%
Sep 30, 2022 -4.39%
Jun 30, 2022 -6.62%
Mar 31, 2022 -3.83%
Dec 31, 2021 -8.82%
Sep 30, 2021 -8.98%
Jun 30, 2021 -1.39%
Mar 31, 2021 -2.55%
Dec 31, 2020 -0.12%
Sep 30, 2020 3.03%
Jun 30, 2020 6.19%
Mar 31, 2020 -39.02%
Dec 31, 2019 -36.67%
Sep 30, 2019 -6.62%
Jun 30, 2019 11.97%
Mar 31, 2019 10.49%
Dec 31, 2018 4.02%
Sep 30, 2018 1.75%
Jun 30, 2018 15.63%
Mar 31, 2018 -4.84%
Dec 31, 2017 -4.18%
Sep 30, 2017 -28.18%
Jun 30, 2017 -149.85%
Mar 31, 2017 -173.27%